BRIGHT MINDS BIOSCIENCES INC. (DRUG) Gross margin
BRIGHT MINDS BIOSCIENCES INC. (DRUG) gross margin by fiscal year — reported gross profit divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to DRUGSource: SEC XBRL filings · For reference only · Not investment advice
More DRUG financial trends
DRUG RevenueDRUG Net incomeDRUG Net marginDRUG Gross profitDRUG Operating incomeDRUG Operating marginDRUG Operating cash flowDRUG Free cash flowDRUG Capital expendituresDRUG Return on equityDRUG Stock buybacksDRUG Dividends paidDRUG Total assetsDRUG Total liabilitiesDRUG Shareholders’ equityDRUG overview →